HIV i-Base report from the 6th Joint Conference of the British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH)
An essential new PrEP resource was launched at the 6th Joint BHIVA/BASHH conference by the same team that runs the main drug interaction website at Liverpool University.
https://prep-druginteractions.org
The new site is based on two main PrEP resources.
The website is notable for reporting many interactions that might not be included in the summary of product characteristics and product information of each PrEP option. Some of the contraindications might not be expected or otherwise reported and they will be especially important for new versions of injectable PrEP.
Read more here.
Source : HIV i-Base
Related HIV and Co-Infections News
-
[BHIVA/BASHH 2026] HIV i-Base: Limited drug resistance after doxyPEP but inequitable access: uptake of 4CMenB vaccine
-
HIV i-Base: Transgender health in Australia: HIV drops by 94% as PrEP increases over 10 years
-
[Statement] MSF: Gilead stockholders: Demand Gilead sell HIV prevention drug to those who need it
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.